Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst
“Heading into 1Q25, we also believe BPMC could be seen as an attractive target for strategic partnerships, which could boost shares,” JP Morgan writes. With Ayvakit’s launch being a major focus for ...
Ovintiv Shakes Up Portfolio With $2.38 Billion Montney Acquisition And $2 Billion Uinta Basin Sale, Pauses Buyback
Ovintiv Inc. (NYSE: OVV) shares are trading higher after the company inked a definitive purchase agreement to acquire certain Montney assets from Paramount Resources Ltd. (OTC: PRMRF ), in an all-cash ...
The New York Times1d
The Learning Network
A small cohort of turkey hunters wants more people to understand the beauty and challenge of hunting for your supper. What are your thoughts on hunting? By Jeremy Engle How do you feel about ...